Cargando…
Bergamottin a CYP3A inhibitor found in grapefruit juice inhibits prostate cancer cell growth by downregulating androgen receptor signaling and promoting G0/G1 cell cycle block and apoptosis
Prostate cancer is the second leading cause of cancer related death in American men. Several therapies have been developed to treat advanced prostate cancer, but these therapies often have severe side effects. To improve the outcome with fewer side effects we focused on the furanocoumarin bergamotti...
Autores principales: | Vetrichelvan, Opalina, Gorjala, Priyatham, Goodman, Oscar, Mitra, Ranjana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476002/ https://www.ncbi.nlm.nih.gov/pubmed/34570813 http://dx.doi.org/10.1371/journal.pone.0257984 |
Ejemplares similares
-
Role of CYP3A5 in Modulating Androgen Receptor Signaling and Its Relevance to African American Men with Prostate Cancer
por: Gorjala, Priyatham, et al.
Publicado: (2020) -
Pharmacological Utilization of Bergamottin, Derived from Grapefruits, in Cancer Prevention and Therapy
por: Ko, Jeong-Hyeon, et al.
Publicado: (2018) -
Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5
por: Mitra, Ranjana, et al.
Publicado: (2017) -
A prospective study of grapefruit and grapefruit juice intake and breast cancer risk
por: Kim, E H, et al.
Publicado: (2008) -
Marginal increase of sunitinib exposure by grapefruit juice
por: van Erp, Nielka P., et al.
Publicado: (2010)